News
07-04-2009, 03:18 AM
A new study published in the July issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) scans in mice can be used to determine whether a novel type of breast cancer treatment is working as intended. Researchers successfully used PET and a specially-developed radioactive compound to image HER2 - a protein often associated with aggressive breast cancer - in breast cancer cells before and after treatment aimed at decreasing HER2 expression.
More... (http://www.medicalnewstoday.com/articles/156371.php)
More... (http://www.medicalnewstoday.com/articles/156371.php)